A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/7/2015 |
| Start Date: | March 2014 |
| Contact: | Francis Worden, M.D. |
| Email: | fworden@umich.edu |
| Phone: | 734-936-0453 |
A retrospective chart review of patients receiving concurrent chemoradiotherapy for
oropharynx cancer was performed to compare clinical data for patients treated prior to the
initiation of the NP clinic with those subsequently seen weekly in the NP clinic. The
variables studied included; rate of hospitalization, dose completion and dose reductions.
The results revealed an overall improvement in all variables for those patients seen in the
weekly NP clinic.
To further analyze this data a randomized, prospective study is proposed to validate the
findings of the retrospective study. It is predicted that a weekly NP led clinic will
decrease costly hospitalizations, increase patient treatment completion and improve overall
patient quality of life and satisfaction.
oropharynx cancer was performed to compare clinical data for patients treated prior to the
initiation of the NP clinic with those subsequently seen weekly in the NP clinic. The
variables studied included; rate of hospitalization, dose completion and dose reductions.
The results revealed an overall improvement in all variables for those patients seen in the
weekly NP clinic.
To further analyze this data a randomized, prospective study is proposed to validate the
findings of the retrospective study. It is predicted that a weekly NP led clinic will
decrease costly hospitalizations, increase patient treatment completion and improve overall
patient quality of life and satisfaction.
Inclusion Criteria:
- Have a diagnosis of stage III or IV HNC
- Are initiating concurrent chemotherapy and radiation
- Are able and willing to sign informed consent
- Ages 18 years or older
- ECOG (Eastern Cooperative Oncology Group) score of 0 or 1 (The ECOG score attempt to
quantify cancer patients' general well-being and activities of daily life)
- Able to read and complete the required survey
Exclusion Criteria:
- Cannot provided informed consent
- Any medical or psychiatric illness which in the opinion of the principal investigator
would compromise the patient's ability to tolerate this treatment.
- Have a history of prior cancer within past 5 years (excluding non-melanoma skin
cancer)
- Are unwilling or unable to complete the required QOL (Quality of Life) survey
We found this trial at
1
site
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health System The University of Michigan is home to one of the...
Click here to add this to my saved trials
